21 May 2013
Keywords: Bayer, OncoMed Pharma, Licensing, Stem cell therapeutics, Wnt pathway
Article | 18 June 2010
It seems there is no end to the mega-dollar licensing accords that research-based drug majors are signing. The latest is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 June 2010
20 May 2013
© 2013 thepharmaletter.com